Administrative Guidance against K.K. Kokoro

株式会社こころ (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareJuly 28, 2020

Action summary

Company: K.K. KokoroRomanized
Original: 株式会社こころ
Governing law: Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type: Administrative Guidance
行政指導
Action date: July 28, 2020
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

Based on the submission of two types of CBD products, a total of eight products, the ingredients were analyzed. The analysis revealed that three units of CBD Oil Pro900 (10 mL capacity) and two units of CBD Oil Pro2700 (30 mL capacity) contained trace amounts of the cannabis component THC.

Show original Japanese text

同社が回収したCBD製品２種類８製品の提出を受け、成分の分析を行いました。分析の結果、CBDオイルPro900（容量10mL）3製品、CBDオイルPro2700（容量30mL）2製品から、微量の大麻成分THCが検出されました。

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when K.K. Kokoro has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Language

日本語版を見る (Japanese)

Company info

English name: K.K. Kokoro Romanized
Japanese name: 株式会社こころ

See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.